Glaxosmithkline | GSK - أرباح التشغيل

سعر السهم
51.41
التغيير اليومي
-7.71 -13.04%
شهريا
-13.25%
سنويا
29.01%
Q2 التوقعات
53.52




أرباح التشغيل تغيير تاريخ
AbbVie USD 4.73B 1.08B 2026-03
Amgen USD 3.96B 464M 2025-12
AstraZeneca USD 7.11B 4.14B 2026-03
Aurora Cannabis CAD -35.79M 19.88M 2025-12
Bausch Health Companies USD 719M 2M 2025-12
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Canopy Growth CAD -12.66M 1.64M 2025-12
Corcept Therapeutics USD 4.49M 5.73M 2025-12
Drreddys Laboratories INR 14.33B 2.51B 2025-12
Eli Lilly USD 8.99B 599.9M 2025-12
GlaxoSmithKline GBP 2.29B 856M 2026-03
Glaxosmithkline GBP 2.3B 1.46B 2025-12
J&J USD 6.62B 1.03B 2026-03
Merck USD 6.24B 318M 2025-12
Novartis USD 4.24B 171M 2026-03
Pacira USD 3.19M 9.96M 2025-12
Perrigo USD 84.4M 9M 2025-12
Pfizer USD 4.65B 3.99B 2025-12
Phibro Animal Health USD 54.99M 2.36M 2025-12
Prestige Brands USD 82.49M 2.82M 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
Sanofi EUR 1.94B 239M 2026-03
Supernus Pharmaceuticals USD 13.82M 74.01M 2025-12
Takeda JPY 168.82B 479.89B 2025-12
Teva Pharmaceutical Industries USD 758M 271M 2026-03
Zoetis USD 835M 101M 2025-12